Back to GetFilings.com



 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 


 

FORM 10-Q

 

 

ý                                 QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

                For the quarterly period ended September 30, 2004

 

o                                 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

                For the transition period from                    to                  

 

                Commission File Number:  0-21134

 

Paligent Inc.


 

(Exact name of registrant as specified in its charter)

 

Delaware

 

04-2893483

(State or other jurisdiction of

 

(I.R.S. Employer

incorporation or organization)

 

Identification No.)

 

 

 

10 East 53rd Street, New York, New York

 

10022

(Address of principal executive offices)

 

(zip code)

 

 

 

(212) 755-5461
Registrant’s telephone number, including area code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 

YES  ý      NO  o

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).

 

YES  o      NO  ý

 

The number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

 

Class

 

Outstanding as of November 5, 2004

 

 

 

Common Stock, $0.01 par value

 

32,490,948

 



 

PALIGENT INC.

 

INDEX

 

 

 

 

 

Page(s)

PART I.

FINANCIAL INFORMATION

 

 

 

 

 

 

Item 1.

Financial Statements

 

 

 

 

 

 

 

Condensed Consolidated Balance Sheets
September 30, 2004 (unaudited) and December 31, 2003

 

3

 

 

 

 

 

Condensed Consolidated Statements of Operations (unaudited)
Three and nine months ended September 30, 2004 and 2003

 

4

 

 

 

 

 

 

Condensed Consolidated Statements of Cash Flows (unaudited)
Nine months ended September 30, 2004 and 2003

 

5

 

 

 

 

 

 

Notes to Condensed Consolidated Financial Statements (unaudited)

6-9

 

 

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

10-12

 

 

 

 

Item 3

Quantitative and Qualitative Disclosure About Market Risk

13

 

 

 

 

Item 4.

Controls and Procedures

13

 

 

 

 

PART II.

OTHER INFORMATION

 

 

 

 

 

Item 1.

Legal Proceedings

14

 

 

 

 

Item 6.

Exhibits and Reports on Form 8-K

14

 

 

 

 

SIGNATURES

 

 

15

 

 

 

 

EXHIBIT INDEX

 

16

 

 

2



 

PALIGENT INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

 

 

 

September 30, 2004

 

December 31, 2003

 

 

 

(unaudited)

 

 

 

ASSETS

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

46,165

 

$

41,321

 

Current portion of subtenant receivable

 

 

100,000

 

Property held for sale

 

 

10,000

 

Prepaid expenses and other current assets

 

27,746

 

 

Total current assets

 

73,911

 

151,321

 

 

 

 

 

 

 

Property and equipment, net

 

1,409

 

2,813

 

Subtenant receivable

 

 

25,000

 

Security deposits

 

 

9,543

 

Total assets

 

$

75,320

 

$

188,677

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ DEFICIT

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable and accrued expenses

 

$

39,046

 

$

132,935

 

Accrued professional services

 

20,300

 

34,100

 

Accrued rent

 

33,415

 

 

Due to related party

 

140,000

 

111,189

 

Capital lease obligation

 

 

10,000

 

Total current liabilities

 

232,761

 

288,224

 

 

 

 

 

 

 

Deferred rent

 

 

22,262

 

 

 

 

 

 

 

Stockholders’ deficit:

 

 

 

 

 

Common stock, $.01 par value; 75,000,000 shares authorized; 32,490,948 shares issued and outstanding at September 30, 2004 and December 31, 2003

 

324,910

 

324,910

 

Additional paid-in capital

 

154,634,974

 

154,634,974

 

Accumulated deficit

 

(155,117,325

)

(155,081,693

)

Total stockholders’ deficit

 

(157,441

)

(121,809

)

Total liabilities and stockholders’ deficit

 

$

75,320

 

$

188,677

 

 

The accompanying notes are an integral part of the condensed consolidated financial statements.

 

3



 

PALIGENT INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited)

 

 

 

Three months ended
September 30,

 

Nine months ended
September 30,